5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity
- 2 August 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (15) , 3993-3996
- https://doi.org/10.1016/j.bmcl.2004.05.037
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABAA signalingNeuropharmacology, 2004
- The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of AnxietyNeuropsychopharmacology, 2004
- 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic ActivityJournal of Medicinal Chemistry, 2002
- Anxiolytic-like activity of the mGluR5 antagonist MPEP: A comparison with diazepam and buspironePharmacology Biochemistry and Behavior, 2002
- Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant miceNature Neuroscience, 2001
- Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonistBritish Journal of Pharmacology, 2001
- Discovery of subtype-selective metabotropic glutamate receptor ligands using functional HTS assaysDrug Discovery Today, 2000
- Glutamate receptors in the mammalian central nervous systemProgress in Neurobiology, 1998
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5Neuropharmacology, 1995